NCT00645164 is a Phase 1 clinical trial of Ointment Vehicle in Healthy, sponsored by Healthpoint.

Who is sponsoring NCT00645164?

NCT00645164 is sponsored by Healthpoint.

What drugs are being tested in NCT00645164?

Interventions in NCT00645164: Ointment Vehicle, Xenaderm.

Is NCT00645164 still recruiting?

NCT00645164 is currently completed. Last updated 1 June 2010.

Are results published for NCT00645164?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2010-06-01 · How we verify

NCT00645164

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Evaluation of the Photoallergy Potential of Xenaderm Ointment

Completed Phase 1 Results posted Last updated 1 June 2010

What this trial tests

Phase 1 trial testing Ointment Vehicle in Healthy in 59 participants. Completed in 1 June 2008.

Timeline

1 March 2008

Primary endpoint
1 May 2008

1 June 2008

Quick facts

Lead sponsor	Healthpoint
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	quadruple
Enrollment	59
Start date	1 March 2008
Primary completion	1 May 2008
Estimated completion	1 June 2008
Sites	1 location across United States

Drugs / interventions tested

Ointment Vehicle
Xenaderm — full drug profile →

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

Healthpoint — full company profile →

Who can join

18 and older, any sex, with Healthy. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Frequency Distribution of Skin Irritation Scores
Time frame: 48-hours post irradiation
Scores based on skin irritation scale of 0 (no reaction) to 7 (large vesiculo-bullous reaction) in whole units. Photoallergic reactions were characterized by irritation scores of 3 or higher.

Sponsor's own description

The product is being tested to see if exposure to light causes photoallergic reactions on the skin.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Ointment Vehicle

Trials testing the same drug.

NCT01300052 — AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type Psoriasis · Phase 2 · completed

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00645164 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Healthpoint
Last refreshed: 1 June 2010

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00645164.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing